MYCN and ALK copy number was assessed in cfDNA samples from 16 patients with active neuroblastoma (14 at initial presentation and 2 at metastatic recurrence) and 3 patients in remission (Figure 4). This evidence concerns the gene ALK and neuroblastoma.